Genetic Testing Market Material Type, Application and End-User Industry - Global Opportunity Analysis and Industry Forecast 2025


16 May 2019 - Global Genetic Testing Market is expected to grow at a significant CAGR of 10.32% in the upcoming period as the scope and its applications are rising enormously across the globe. Genetic Testing, also termed as DNA testing, is a process of analyzing the person’s chromosomes or DNA for the presence of particular DNA sequences that encode for traits of interest. It is mainly used to detect inherited disease causing disease and/or genes causing mutations.

          

Prevalence of diseases like cardiovascular and cancer, growth in acceptance of IT solutions for genetic testing, growing awareness regarding genetic services, and rising occurrence of common autoimmune diseases are documented as the major factors that are estimated to enhance the growth in the years to come.

However, high cost of genetic tests and lack of awareness regarding genetic services in developing countries are the factors that may restrain overall market in the years to come. Genetic Testing Market is segmented based on test type, end user, application, and region.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/genetic-testing-market

Pharmacogenomics testing, prenatal testing, predictive & presymptomatic testing, and newborn screening are the test types that could be explored in Genetic Testing in the forecast period. In terms of revenue, predictive & presymptomatic testing sector accounted for the substantial market share of Genetic Testing and is estimated to lead the overall market in the upcoming period. This may be because of growing awareness regarding diseases like cancer and early diagnosis of diseases.

Specialty clinics, hospital-based laboratories, diagnostics laboratories, and the other end users could be explored in Genetic Testing and are estimated to lead the overall market in the near future. The hospital-based laboratories sector accounted for the significant market share and is estimated to grow at the highest CAGR in the years to come. This may be because of the growing number of hospitals. In addition, diagnostic laboratories sector is estimated to grow at the fastest pace in the near future.

The market may be categorized based on applications like autoimmune diseases, oncology, infectious diseases, and the others that could be explored in the forecast period. The oncology sector accounted for the substantial market share of Genetic Testing and is estimated to continue its dominance in the coming years. This may be because high occurrence of cancer across the globe.

Globally, North America accounted for the substantial market share of Genetic Testing and is estimated to lead the overall market in the upcoming period. The reason behind the overall market growth could be presence of developed healthcare infrastructure, rising use of latest technology for new discoveries in the field of genetic markers, and presence of key manufacturers in this region. The United States is the major consumer of Genetic Testing in this region.

Europe and the Asia Pacific are estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the fastest pace in the foremost period. The aspects that may be ascribed to the growth comprise government and private organization initiative by funding healthcare industry.

The key players of genetic testing market are CENTOGENE AG, Elitech Group, Illumina, Inc., ThermoFisher Scientific, Abbott Molecular Inc., Eurofins Scientific, 23 And Me, BJI Tech, Roche Diagnostics, Blueprint Genetics, and Qiagen. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition.

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/genetic-testing-market/request-sample


Market Segment:

This report studies the global Genetic Testing market, analyzes and researches the Genetic Testing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• GeneDx
• Invitae
• Pathway Genomics
• Counsyl
• Asper Biotech
• GenePlanet
• Courtagen Life Sciences
• Gene By Gene
• Natera, Inc
• Regulatory
• GeneTests
• United Gene
• HI Gene
• Berry Genomics
• 23andMe
• 360Jiyin

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia



Location: Bridge of Orchy PA36 4AG, UK

Comments

Post a Comment

Popular posts from this blog

Thermal Interface Materials Market Revenue, Share and Growth Rate to 2030

  The global thermal interface materials (TIMs) market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.89 billion by 2030, registering a strong CAGR of 11.6% from 2025 to 2030. Growth in this market is primarily driven by the increasing adoption of consumer electronics such as smartphones, laptops, gaming systems, and wearable devices, which require efficient heat dissipation to maintain performance. Similarly, the rising use of industrial automation technologies in developing economies, combined with the growing disposable income of the middle-class population, is significantly boosting demand for TIMs. These materials are specifically engineered to be applied between two hard surfaces often between electronic components and heat sinks to facilitate efficient heat conduction, ensuring safe operation even as devices become smaller, faster, and more powerful. The diverse commercial availability of TIMs in multiple formats, including grea...
Read more

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more